202264-03-7 Usage
Purpose
Medication used to treat rheumatoid arthritis
Works by reducing inflammation and slowing down the progression of the disease
Classification
Disease-modifying antirheumatic drug (DMARD)
Usage
Often used in combination with other medications for best results
Form
Tablet
Dosage
Typically taken once a day
Common side effects
Diarrhea, nausea, and hair loss
Serious side effects
Liver problems and lung disease (rare cases)
Precaution
Discuss potential risks and benefits with a healthcare professional before starting treatment
Check Digit Verification of cas no
The CAS Registry Mumber 202264-03-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,2,6 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 202264-03:
(8*2)+(7*0)+(6*2)+(5*2)+(4*6)+(3*4)+(2*0)+(1*3)=77
77 % 10 = 7
So 202264-03-7 is a valid CAS Registry Number.
202264-03-7Relevant academic research and scientific papers
PHTHALIMIDO ARYLPIPERAZINES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
-
Example 3, (2010/01/31)
This invention relates to a series of substituted piperazines of Formula II, as well as enantiomers thereof These compounds are useful in the manufacture of pharmaceutical compositions.
Design, synthesis, and structure-activity relationships of phthalimide- phenylpiperazines: A novel series of potent and selective {1a)-adrenergic receptor antagonists
Kuo, Gee-Hong,Prouty, Catherine,Murray, William V.,Pulito, Virginia,Jolliffe, Linda,Cheung, Peter,Varga, Sally,Evangelisto, Mary,Wang, Jian
, p. 2183 - 2195 (2007/10/03)
Beginning from the screening hit and literature α1-adrenergic compounds, a hybridized basic skeleton A was proposed as the pharmacophore for potent and selective α(1a)-AR antagonists. Introduction of a hydroxy group to increase the flexibility
